Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Aug 14;14(8):e0221314. doi: 10.1371/journal.pone.0221314. eCollection 2019.

2.

The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.

Shadick NA, Gerlanc NM, Frits ML, Stolshek BS, Brady BL, Iannaccone C, Collier D, Cui J, Mutebi A, Weinblatt ME.

Clin Rheumatol. 2019 Jul 29. doi: 10.1007/s10067-019-04649-4. [Epub ahead of print]

PMID:
31353421
3.

Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Apr 19;14(4):e0214981. doi: 10.1371/journal.pone.0214981. eCollection 2019. Erratum in: PLoS One. 2019 Aug 14;14(8):e0221314.

4.

Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, Gill RR, Hatabu H, Nishino M, Murphy DJ, Iannaccone CK, Mahmoud TG, Frits ML, Lu B, Rosas IO, Dellaripa PF, Weinblatt ME, Karlson EW, Shadick NA, Doyle TJ.

Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. doi: 10.1002/art.40904. Epub 2019 Aug 4.

PMID:
30951251
5.

Incidence and predictors of dyspnea on exertion in a prospective cohort of patients with rheumatoid arthritis.

Sparks JA, Doyle TJ, He X, Pan B, Iannaccone C, Frits ML, Dellaripa PF, Rosas IO, Lu B, Weinblatt ME, Shadick NA, Karlson EW.

ACR Open Rheumatol. 2019 Mar;1(1):4-15. doi: 10.1002/acr2.1001. Epub 2019 Mar 15.

PMID:
30923795
6.

Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.

Ahmad HA, Alemao E, Guo Z, Iannaccone CK, Frits ML, Weinblatt M, Shadick NA.

Adv Ther. 2018 Feb;35(2):232-242. doi: 10.1007/s12325-017-0657-x. Epub 2018 Jan 25.

7.

Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study.

Alemao E, Guo Z, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME.

Semin Arthritis Rheum. 2018 Apr;47(5):630-638. doi: 10.1016/j.semarthrit.2017.10.009. Epub 2017 Oct 13.

PMID:
29241640
8.

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.

Alemao E, Joo S, Kawabata H, Al MJ, Allison PD, Rutten-van Mölken MP, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):308-17. doi: 10.1002/acr.22678.

9.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.

10.

Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis.

Mjaavatten MD, Radner H, Yoshida K, Shadick NA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

J Rheumatol. 2014 Dec;41(12):2370-8. doi: 10.3899/jrheum.140306. Epub 2014 Oct 15.

11.

Clinical characteristics of RA patients with secondary SS and association with joint damage.

Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP.

Rheumatology (Oxford). 2015 May;54(5):816-20. doi: 10.1093/rheumatology/keu400. Epub 2014 Oct 13.

12.

Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.

Mjaavatten MD, Radner H, Yoshida K, Shadick NA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

Semin Arthritis Rheum. 2015 Feb;44(4):399-404. doi: 10.1016/j.semarthrit.2014.08.003. Epub 2014 Aug 27.

13.

Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors.

Lee YC, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, Cui J.

Arthritis Rheumatol. 2014 Aug;66(8):2006-14. doi: 10.1002/art.38682.

14.

Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.

Doyle TJ, Dellaripa PF, Batra K, Frits ML, Iannaccone CK, Hatabu H, Nishino M, Weinblatt ME, Ascherman DP, Washko GR, Hunninghake GM, Choi AMK, Shadick NA, Rosas IO.

Chest. 2014 Jul;146(1):41-50. doi: 10.1378/chest.13-1394.

15.

Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis.

Lu B, Rho YH, Cui J, Iannaccone CK, Frits ML, Karlson EW, Shadick NA.

J Rheumatol. 2014 Jan;41(1):24-30. doi: 10.3899/jrheum.130074. Epub 2013 Dec 1.

16.

A randomized controlled trial of an internal family systems-based psychotherapeutic intervention on outcomes in rheumatoid arthritis: a proof-of-concept study.

Shadick NA, Sowell NF, Frits ML, Hoffman SM, Hartz SA, Booth FD, Sweezy M, Rogers PR, Dubin RL, Atkinson JC, Friedman AL, Augusto F, Iannaccone CK, Fossel AH, Quinn G, Cui J, Losina E, Schwartz RC.

J Rheumatol. 2013 Nov;40(11):1831-41. doi: 10.3899/jrheum.121465. Epub 2013 Aug 15.

17.

Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.

Lillegraven S, Paynter N, Prince FH, Shadick NA, Haavardsholm EA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

Arthritis Care Res (Hoboken). 2013 Apr;65(4):526-33. doi: 10.1002/acr.21870.

18.

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.

Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH.

Ann Rheum Dis. 2012 May;71(5):681-6. doi: 10.1136/ard.2011.154625. Epub 2011 Oct 12.

PMID:
21994234
19.

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.

Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME, Solomon DH.

Arthritis Res Ther. 2011 Jun 8;13(3):R83. doi: 10.1186/ar3353.

20.

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA.

Rheumatology (Oxford). 2011 Jan;50(1):40-6. doi: 10.1093/rheumatology/keq263. Epub 2010 Sep 16.

PMID:
20847201

Supplemental Content

Loading ...
Support Center